• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP
Click for more information
2.44% 21.0¢

CYNATA THERAPEUTICS LIMITED

Market Cap $37.72M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP
Ann: DFU Clinical Trial Enrolment Complete 		16/04/24 19 3.6K
16/04/24 Last post  Pledge Comments Created with Sketch.  19  Views Created with Sketch.  3.6K 
CYP
Timelines 		15/04/24 4 847
15/04/24 Last post  viewph Comments Created with Sketch.  4  Views Created with Sketch.  847 
CYP
Ann: Capital Raising Presentation
2 3 4
05/04/24 226 53K
05/04/24 Last post  JabraD Comments Created with Sketch.  226  Views Created with Sketch.  53K 
CYP
Ann: First Patient Treated in Phase 2 GvHD Trial
2
05/04/24 61 10K
05/04/24 Last post  pfeifer1982 Comments Created with Sketch.  61  Views Created with Sketch.  10K 
CYP
Going forward...
34 35 36
04/04/24 2.1K 673K
04/04/24 Last post  whaleshark Comments Created with Sketch.  2.1K  Views Created with Sketch.  673K 
CYP
Ann: EU Approval for Phase 2 CYP-001 Trial in GvHD 		22/03/24 8 1.4K
22/03/24 Last post  OceanView Comments Created with Sketch.  8  Views Created with Sketch.  1.4K 
CYP
The Phase I/IIb Nereid Study Is Now Registered 		22/03/24 19 2.9K
22/03/24 Last post  truss20 Comments Created with Sketch.  19  Views Created with Sketch.  2.9K 
CYP
News: CYP Cynata Therapeutics Gets EU Regulatory & Ethics Approval For Phase 2 Trial In Graft... 		20/03/24 1 313
20/03/24 Last post  Pledge Comments Created with Sketch.  1  Views Created with Sketch.  313 

See All Discussions arrow Created with Sketch.

Timeline

DFU Clinical Trial Enrolment Complete
08 Apr 08:58
 
EU Approval for Phase 2 CYP-001 Trial in GvHD
20 Mar 08:55
 
Cynata Presenting at Advanced Therapies Congress
18 Mar 08:52
 
First Patient Treated in Phase 2 GvHD Trial
05 Mar 08:54
 
Cynata Appoints New Chief Business Officer
29 Feb 09:19
 
Encouraging Initial Data from CYP-006TK DFU Trial
26 Feb 09:01
 
View More arrow Created with Sketch.

Featured News

LU7 Lithium Universe shares jump on below-expected SPP result
right-arrow Created with Sketch.
FXG Market purrs with approval of Felix's 90% gold recovery in Alaska
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
OZM OzAurum Resources ups the ante on the charge for lithium in Brazi
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.

(20min delay)
Last
21.0¢ 		Change
0.005(2.44%) 		Mkt cap ! $37.72M
Open High Low Value Volume
20.5¢ 21.0¢ 20.0¢ $78.21K 380.9K

Buyers (Bids)

No. Vol. Price($)
2 57829 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 56301 2
View Market Depth
Last trade - 16.10pm 16/04/2024 (20 minute delay) ?
Last
21.0¢ 		  Change
0.005 ( 5.00 %)
Open High Low Volume
20.5¢ 21.0¢ 20.5¢ 85588
Last updated 15.41pm 16/04/2024 ?
CYP (ASX) Chart

Top Stories

Market Update: Energy keeps light bright in a sea of red

The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Chariots of fire on pole to meet resurgent US lithium security focus. Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...

Featured News

FXG Market purrs with approval of Felix's 90% gold recovery in Alaska
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.
LU7 Lithium Universe shares jump on below-expected SPP result
right-arrow Created with Sketch.
OZM OzAurum Resources ups the ante on the charge for lithium in Brazi
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.